International Clinical Trial: Phase 1 study to evaluate the safety and the pharmacokinetics of "UI111" and "UIC202006" in healthy adult volunteers under fed state conditions

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (KCT0012576) titled 'Phase 1 study to evaluate the safety and the pharmacokinetics of "UI111" and "UIC202006" in healthy adult volunteers under fed state conditions' on Sept. 8.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Cross-over, Blinding/Masking : Open, Allocation : RCT

Primary Sponsor: Korea United Pharm

Condition:

Endocrine, nutritional and metabolic diseases

Intervention: Drug : 2x4 crossover, 7days wash out period Group A: R(1)-T(2)-R(3)-T(4) Group B: T(1)-R(2)-T(3)-R(4) *Arm R: UIC202006, single dose, under fed condition *Arm T: UI111, single dose, under fed condit...